Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
051
|
Date of Entry 01/14/2019
|
FR Recognition Number
|
3-158
|
Standard | |
ASTM F3320-18 Standard Guide forCoating Characterization of Drug Coated Balloons |
|
Scope/Abstract1.1 This guide describes recommended acute in-vitro characterization methods for drug coated balloon (DCB) coatings. These methods include: coating integrity, coating thickness, drug coating uniformity, and released particulates. Specifically, this guide details:
1.1.1 Characterization of integrity by inspection of the coated balloon surface.
1.1.2 Measurement of coating thickness.
1.1.3 Quantitation of drug coating uniformity (uniformity of drug distribution over the balloon surface) longitudinally and circumferentially.
1.1.4 Quantitation of the number of particulates released, in various ranges, during simulated use testing (insertion, tracking, deployment, retraction, and withdrawal) along with chemical and crystallinity characterization of particulates. |
|
Extent of Recognition
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
N/A |
Drug-Eluting Peripheral Transluminal Angioplasty Catheter |
Class 3
|
ONU
|
N/A |
Drug-Coated Peripheral Transluminal Angioplasty Catheter |
Class 3
|
PRC
|
|
Relevant FDA Guidance and/or Supportive Publications*
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contacts
|
Standards Development Organization
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |